Huawei plans for more AI pharma tie-ups, says healthcare president
Source: The Times of India· Reuters· August 27, 2026
The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and automated laboratories to shorten development timelines and improve efficiency.
This story was reported by The Times of India. Read the full original article:
Read on The Times of India 
